Tweets
#ACR23 Please find my preview article on selected #SLE abstracts to be presented at year’s conference - towards Glucocorticoid-Free zone in lupus @RheumNow
https://t.co/1kM7LWc64V https://t.co/WK9X7UpsNi
Md Yuzaiful Md Yusof ( View Tweet )
2 years 3 months ago
High hs-CRP predicts PsO -> PsA?
Abs#0484 #ACR23 @RheumNow
589 PsO pts wo PsA, followed mean 7.5 years
57 pts developed PsA (1.2 events/yr)
Higher levels of b/l hs-CRP seen w: arthrlalgia, obesity, females
Higher hs-CRP ass. w/ PsA - p=0.002, but HR only 1.03 (CI 1.01-1.05)
Eric Dein ( View Tweet )
2 years 3 months ago
Long term results of the MAINRITSAN study (Maintenance Remission w/ RTX in Systemic AAV) showed fixed-schedule RTX superior to AZA in preventing major relapses at 84mos (HR 0.38), but tailored-RTX assoc w/ incr risk of major relapse (HR 2.92) https://t.co/vucBYeM1P5 https://t.co/YqdqZWFhfd
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
In young patients who have a spinal MRI, lesions are reported in most patients, and similar in males:females. SIJ MRI findings are reported in one out of three patients, being more frequently in males @DiegoBenavent Abst #160 #ACR23 @RheumNow https://t.co/aF9WnP7jpY https://t.co/E9UuZ0sWZm
Dr. Antoni Chan ( View Tweet )
2 years 3 months ago
#Benefits of #hudroxychloroquine - reduced lipids, clots, CV events, infection AND now improved #fatty #liver #NAFLD….@RheumNow #ACR23 @ACRheum https://t.co/Y43JETY6F3
Janet Pope ( View Tweet )
2 years 3 months ago
Sarilumab for relapsing of PMR. Any thing to to taper off prednisone quickly.
#ACR23 , year in review.
Lost of good studies and smart discussions @RheumNow at Make rheum for PMR month. https://t.co/VyRP8ls3OC
Nouf Al hemmadi ( View Tweet )
2 years 3 months ago
Thank you @synovialjoints @RheumNow for highlighting our work
#ACR23 #ACRambassador
@ACRheum
@ArLARheumatolog
#ARCH_ArLAR https://t.co/rphaODphD1
Nelly ZIADE 🍀 @Nellziade ( View Tweet )
2 years 3 months ago
If successful you may need how to pronounce these emerging therapeutics in #inflammatory #arthritis @RheumNow #ACR23 @ACRheum https://t.co/aOogwQCsCM
Janet Pope ( View Tweet )
2 years 3 months ago
One for you, one for me!
So many pasalubong char
@RHEUMarampa
@RheumNow
#acr23 #ACRambassador https://t.co/v0mZ9vbadx
Lisa 🐳🗺🧭 @rheumarhyme ( View Tweet )
2 years 3 months ago
Cellular based biology explanation of sex bias in ARDs 👀
Data from AMP w/ sc-RNA seq from synovial tissue shows:
Enriched inflammatory pathways in females synovial macrophages clusters vs. males
Basis for gender specific treatment strategies?
@RheumNow ABST0724 #ACR23 https://t.co/1p8PDIRNoI
Aurelie Najm ( View Tweet )
2 years 3 months ago
Is there a difference in secukinumab vs. adalimumab biosimilar on radiographic progression in a subgroup of axSpA pts with syndesmophytes or CRP levels?
Radiographic progression equally low in both drugs
NO difference in syndesmophytes or CRP
@RheumNow #ACR23 Abs#0522 https://t.co/1TBKAxuKPE
Robert B Chao, MD ( View Tweet )
2 years 3 months ago
In their study, Dr Deng et al identified TRAF5 as susceptible gene for SLE-PAH
✳️TRAF5 deficiency activates BMP/TGFB signaling w/⬆️PAEC apoptosis
✳️TRAF5 overexpression attenuated PAH sxs in mice
TRAF5 as potential BM for dx/novel tx target in SLE-PAH?
#ACR23 ABST0723 @RheumNow https://t.co/WT9vQo8y8s
sheila ( View Tweet )
2 years 3 months ago
